Medicare Enrolled

Dr. Ashley Olsin, FNP

Family Medicine · Dallas, TX
Consulting-driven
6301 GASTON AVE STE 100W, Dallas, TX 75214
2148273610
In practice since 2017 (8 years)
NPI: 1447771167 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Olsin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Olsin? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Olsin

Dr. Ashley Olsin is a family medicine specialist in Dallas, TX, with 8 years of NPI registration.

Between the years covered by Open Payments, Dr. Olsin received a total of $35,888 from 56 pharmaceutical and/or device companies across 664 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Olsin is Moderate — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 8 years in practice $35,888 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$35,888
Total received (2020-2024)
Avg $7,178/year across 5 years
Top 1% in TX for family medicine
56
Companies
664
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$14,929 (41.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$13,155 (36.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,804 (21.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$15,654
2023
$9,223
2022
$6,469
2021
$4,522
2020
$19

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Lundbeck LLC
$24,586
ABBVIE INC.
$2,084
UPSHER-SMITH LABORATORIES LLC
$1,946
AbbVie Inc.
$811
Teva Pharmaceuticals USA, Inc.
$533
ARGENX US, INC.
$438
Lilly USA, LLC
$388
PFIZER INC.
$372
Genentech USA, Inc.
$311
Biogen, Inc.
$309
SK Life Science, Inc.
$229
Amgen Inc.
$220
Biohaven Pharmaceutical Holding Company Ltd.
$214
Allergan, Inc.
$210
Biohaven Pharmaceuticals, Inc.
$209
Janssen Pharmaceuticals, Inc
$205
Novartis Pharmaceuticals Corporation
$200
Amneal Pharmaceuticals LLC
$194
Alnylam Pharmaceuticals Inc.
$193
UCB, Inc.
$188
Merz Pharmaceuticals, LLC
$183
Sunovion Pharmaceuticals Inc.
$180
Neurocrine Biosciences, Inc.
$160
IMPEL PHARMACEUTICALS INC.
$147
NOVARTIS PHARMACEUTICALS CORPORATION
$135
ACADIA Pharmaceuticals Inc
$120
TG Therapeutics, Inc.
$114
Eisai Inc.
$112
Ipsen Biopharmaceuticals, Inc
$89
Alexion Pharmaceuticals, Inc.
$85
Takeda Pharmaceuticals U.S.A., Inc.
$66
Grifols USA, LLC
$60
Horizon Therapeutics plc
$59
CATALYST PHARMACEUTICALS, INC.
$59
Acorda Therapeutics, Inc
$55
Octapharma USA, Inc.
$49
EMD Serono, Inc.
$34
HARMONY BIOSCIENCES LLC
$32
Avion Pharmaceuticals
$27
Kyowa Kirin, Inc.
$27
CSL Behring
$24
NS Pharma, Inc.
$19
Avadel CNS Pharmaceuticals, LLC
$18
Scilex Pharmaceuticals Inc.
$18
Celgene Corporation
$18
Otsuka America Pharmaceutical, Inc.
$17
Avanir Pharmaceuticals, Inc.
$15
Almatica Pharma LLC
$15
Neurelis, Inc.
$15
BANNER LIFE SCIENCES, LLC
$15
ARBOR PHARMACEUTICALS, INC.
$14
GENZYME CORPORATION
$14
IDORSIA PHARMACEUTICALS US INC
$14
TG THERAPEUTICS, INC.
$13
Supernus Pharmaceuticals, Inc.
$13
Collegium Pharmaceutical, Inc.
$12
Top 3 companies account for 79.7% of total payments
Associated products mentioned in payments ›
ADUHELM · AGAMREE · AIMOVIG · AJOVY · AMYVID · APTIOM · AUSTEDO · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BRIUMVI · Briviact · COMIRNATY · DAYBUE · DUOPA · DYSPORT · Dhivy · ELYXYB - celecoxib · EMGALITY · Enspryng · FIRDAPSE · Fycompa · GAMMAGARD · Gamunex-C · HYQVIA · Hizentra · Horizant · INBRIJA · INGREZZA · KESIMPTA · KYNMOBI · LUMRYZ · Leqembi · NAPRELAN · NEXVIAZYME · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONPATTRO · OXTELLAR XR · Ocrevus · Ongentys · PANZYGA · PAXLOVID · Ponvory · QUDEXY · QULIPTA · QUVIVIQ · RYTARY · Rystiggo · SKYCLARYS · SOLIRIS · Skyclarys · Soliris · TOSYMRA · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VILTEPSO · VYEPTI · VYVGART · VYVGART HYTRULO · Wakix · Xembify · Xeomin · ZEMBRACE SYMTOUCH · ZEPOSIA · ZOMIG · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (42%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 1% for family medicine in TX.

Looking for a family medicine specialist in Dallas?
Compare family medicine physicians in the Dallas area by procedure volume, costs, and industry payment transparency.
Browse family medicine physicians nearby

Geographic Context

Family medicine physicians within 10 mi
1,542
Per 100K population
59.2
County median income
$74,149
Nearest hospital
WHITE ROCK MEDICAL CENTER
2.4 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Moderate. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Olsin is a family medicine specialist, with consulting-driven industry engagement in the top 1% of TX peers.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Olsin receive payments from pharmaceutical companies?
Yes. Dr. Olsin received a total of $35,888 from 56 companies across 664 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Olsin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →